Source: Eur Respir Mon; 2003: 25: 219–227
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Manes, N. Galiè, A. Branzi. Women and pulmonary arterial hypertension. Eur Respir Mon; 2003: 25: 219–227

Member's Comments

No comment yet.

Related content which might interest you: The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012 Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018 Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012 Pregnancy and birth control in pulmonary hypertension Source: Eur Respir Mon 2012; 57: 208-218 Year: 2012 An epidemiological study of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: 104-109 Year: 2007 Pregnancy outcomes in pulmonary arterial hypertension in the modern management era}, Source: Eur Respir J 2012; 40: 881-885 Year: 2012 A USA-based registry for pulmonary arterial hypertension: 1982 2006 Source: Eur Respir J 2007; 30: 1103-1110 Year: 2007 Favorable pregnancy outcomes in women with predominantly mild pulmonary arterial hypertension Source: Virtual Congress 2021 – All about pulmonary arterial hypertension Year: 2021 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Maternal blood pressure throughout pregnancy, gestational hypertension, and preeclampsia and offspring asthma Source: International Congress 2019 – More and more COPD Year: 2019 Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Registries for paediatric pulmonary hypertension Source: Eur Respir J 2013; 42: 580-583 Year: 2013 Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 Pulmonary arterial hypertension in patients with HIV infection Source: Eur Respir Mon 2012; 57: 82-93 Year: 2012 Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Variation in mortality from pulmonary hypertension by aetiology Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015